Apnimed posts results of Phase 3 AD109 trial in obstructive sleep apnea
The study, enrolling 660 participants, compared AD109 to placebo over 1 year and was completed with primary data posted on November 3, 2026. It began on August 28, 2023 and reached primary completion on May 7, 2025.
Primary source
ClinicalTrials.gov results record, November 3, 2026
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
Read the source: Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation